The Market Reports

Index

1 Mefenamic Acid Market Overview
1.1 Product Overview and Scope of Mefenamic Acid
1.2 Mefenamic Acid Segment by Type
1.2.1 Global Mefenamic Acid Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Patent
1.2.3 Generic
1.3 Mefenamic Acid Segment by Application
1.3.1 Mefenamic Acid Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 On-line
1.4 Global Mefenamic Acid Market Size Estimates and Forecasts
1.4.1 Global Mefenamic Acid Revenue 2016-2027
1.4.2 Global Mefenamic Acid Sales 2016-2027
1.4.3 Mefenamic Acid Market Size by Region: 2016 Versus 2021 Versus 2027

2 Mefenamic Acid Market Competition by Manufacturers
2.1 Global Mefenamic Acid Sales Market Share by Manufacturers (2016-2021)
2.2 Global Mefenamic Acid Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Mefenamic Acid Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Mefenamic Acid Manufacturing Sites, Area Served, Product Type
2.5 Mefenamic Acid Market Competitive Situation and Trends
2.5.1 Mefenamic Acid Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Mefenamic Acid Players Market Share by Revenue
2.5.3 Global Mefenamic Acid Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Mefenamic Acid Retrospective Market Scenario by Region
3.1 Global Mefenamic Acid Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Mefenamic Acid Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Mefenamic Acid Market Facts & Figures by Country
3.3.1 North America Mefenamic Acid Sales by Country
3.3.2 North America Mefenamic Acid Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Mefenamic Acid Market Facts & Figures by Country
3.4.1 Europe Mefenamic Acid Sales by Country
3.4.2 Europe Mefenamic Acid Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Mefenamic Acid Market Facts & Figures by Region
3.5.1 Asia Pacific Mefenamic Acid Sales by Region
3.5.2 Asia Pacific Mefenamic Acid Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Mefenamic Acid Market Facts & Figures by Country
3.6.1 Latin America Mefenamic Acid Sales by Country
3.6.2 Latin America Mefenamic Acid Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Mefenamic Acid Market Facts & Figures by Country
3.7.1 Middle East and Africa Mefenamic Acid Sales by Country
3.7.2 Middle East and Africa Mefenamic Acid Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Mefenamic Acid Historic Market Analysis by Type
4.1 Global Mefenamic Acid Sales Market Share by Type (2016-2021)
4.2 Global Mefenamic Acid Revenue Market Share by Type (2016-2021)
4.3 Global Mefenamic Acid Price by Type (2016-2021)

5 Global Mefenamic Acid Historic Market Analysis by Application
5.1 Global Mefenamic Acid Sales Market Share by Application (2016-2021)
5.2 Global Mefenamic Acid Revenue Market Share by Application (2016-2021)
5.3 Global Mefenamic Acid Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Shionogi Pharma
6.1.1 Shionogi Pharma Corporation Information
6.1.2 Shionogi Pharma Description and Business Overview
6.1.3 Shionogi Pharma Mefenamic Acid Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Shionogi Pharma Product Portfolio
6.1.5 Shionogi Pharma Recent Developments/Updates
6.2 Solitaire Pharmacia
6.2.1 Solitaire Pharmacia Corporation Information
6.2.2 Solitaire Pharmacia Description and Business Overview
6.2.3 Solitaire Pharmacia Mefenamic Acid Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Solitaire Pharmacia Product Portfolio
6.2.5 Solitaire Pharmacia Recent Developments/Updates
6.3 Shinto Organics
6.3.1 Shinto Organics Corporation Information
6.3.2 Shinto Organics Description and Business Overview
6.3.3 Shinto Organics Mefenamic Acid Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Shinto Organics Product Portfolio
6.3.5 Shinto Organics Recent Developments/Updates
6.4 Captab
6.4.1 Captab Corporation Information
6.4.2 Captab Description and Business Overview
6.4.3 Captab Mefenamic Acid Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Captab Product Portfolio
6.4.5 Captab Recent Developments/Updates
6.5 EMS Pharma
6.5.1 EMS Pharma Corporation Information
6.5.2 EMS Pharma Description and Business Overview
6.5.3 EMS Pharma Mefenamic Acid Sales, Revenue and Gross Margin (2016-2021)
6.5.4 EMS Pharma Product Portfolio
6.5.5 EMS Pharma Recent Developments/Updates
6.6 Adelco
6.6.1 Adelco Corporation Information
6.6.2 Adelco Description and Business Overview
6.6.3 Adelco Mefenamic Acid Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Adelco Product Portfolio
6.6.5 Adelco Recent Developments/Updates
6.7 Agron Remedies
6.6.1 Agron Remedies Corporation Information
6.6.2 Agron Remedies Description and Business Overview
6.6.3 Agron Remedies Mefenamic Acid Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Agron Remedies Product Portfolio
6.7.5 Agron Remedies Recent Developments/Updates
6.8 IASIS Pharmaceuticals Hellas
6.8.1 IASIS Pharmaceuticals Hellas Corporation Information
6.8.2 IASIS Pharmaceuticals Hellas Description and Business Overview
6.8.3 IASIS Pharmaceuticals Hellas Mefenamic Acid Sales, Revenue and Gross Margin (2016-2021)
6.8.4 IASIS Pharmaceuticals Hellas Product Portfolio
6.8.5 IASIS Pharmaceuticals Hellas Recent Developments/Updates
6.9 ABL Lifecare
6.9.1 ABL Lifecare Corporation Information
6.9.2 ABL Lifecare Description and Business Overview
6.9.3 ABL Lifecare Mefenamic Acid Sales, Revenue and Gross Margin (2016-2021)
6.9.4 ABL Lifecare Product Portfolio
6.9.5 ABL Lifecare Recent Developments/Updates
6.10 Farmo Quimica
6.10.1 Farmo Quimica Corporation Information
6.10.2 Farmo Quimica Description and Business Overview
6.10.3 Farmo Quimica Mefenamic Acid Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Farmo Quimica Product Portfolio
6.10.5 Farmo Quimica Recent Developments/Updates
6.11 Apotex
6.11.1 Apotex Corporation Information
6.11.2 Apotex Mefenamic Acid Description and Business Overview
6.11.3 Apotex Mefenamic Acid Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Apotex Product Portfolio
6.11.5 Apotex Recent Developments/Updates
6.12 Sanofi Aventis
6.12.1 Sanofi Aventis Corporation Information
6.12.2 Sanofi Aventis Mefenamic Acid Description and Business Overview
6.12.3 Sanofi Aventis Mefenamic Acid Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Sanofi Aventis Product Portfolio
6.12.5 Sanofi Aventis Recent Developments/Updates
6.13 Yung Sine
6.13.1 Yung Sine Corporation Information
6.13.2 Yung Sine Mefenamic Acid Description and Business Overview
6.13.3 Yung Sine Mefenamic Acid Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Yung Sine Product Portfolio
6.13.5 Yung Sine Recent Developments/Updates
6.14 Streuli Pharma,
6.14.1 Streuli Pharma, Corporation Information
6.14.2 Streuli Pharma, Mefenamic Acid Description and Business Overview
6.14.3 Streuli Pharma, Mefenamic Acid Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Streuli Pharma, Product Portfolio
6.14.5 Streuli Pharma, Recent Developments/Updates
6.15 Mankind
6.15.1 Mankind Corporation Information
6.15.2 Mankind Mefenamic Acid Description and Business Overview
6.15.3 Mankind Mefenamic Acid Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Mankind Product Portfolio
6.15.5 Mankind Recent Developments/Updates
6.16 Pfizer
6.16.1 Pfizer Corporation Information
6.16.2 Pfizer Mefenamic Acid Description and Business Overview
6.16.3 Pfizer Mefenamic Acid Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Pfizer Product Portfolio
6.16.5 Pfizer Recent Developments/Updates
6.17 Daiichi Sankyo
6.17.1 Daiichi Sankyo Corporation Information
6.17.2 Daiichi Sankyo Mefenamic Acid Description and Business Overview
6.17.3 Daiichi Sankyo Mefenamic Acid Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Daiichi Sankyo Product Portfolio
6.17.5 Daiichi Sankyo Recent Developments/Updates
6.18 Chemidex Pharma
6.18.1 Chemidex Pharma Corporation Information
6.18.2 Chemidex Pharma Mefenamic Acid Description and Business Overview
6.18.3 Chemidex Pharma Mefenamic Acid Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Chemidex Pharma Product Portfolio
6.18.5 Chemidex Pharma Recent Developments/Updates
6.19 AA Pharma
6.19.1 AA Pharma Corporation Information
6.19.2 AA Pharma Mefenamic Acid Description and Business Overview
6.19.3 AA Pharma Mefenamic Acid Sales, Revenue and Gross Margin (2016-2021)
6.19.4 AA Pharma Product Portfolio
6.19.5 AA Pharma Recent Developments/Updates
6.20 Nisshin Pharmaceutical
6.20.1 Nisshin Pharmaceutical Corporation Information
6.20.2 Nisshin Pharmaceutical Mefenamic Acid Description and Business Overview
6.20.3 Nisshin Pharmaceutical Mefenamic Acid Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Nisshin Pharmaceutical Product Portfolio
6.20.5 Nisshin Pharmaceutical Recent Developments/Updates
6.21 Koa Isei
6.21.1 Koa Isei Corporation Information
6.21.2 Koa Isei Mefenamic Acid Description and Business Overview
6.21.3 Koa Isei Mefenamic Acid Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Koa Isei Product Portfolio
6.21.5 Koa Isei Recent Developments/Updates
6.22 Teva
6.22.1 Teva Corporation Information
6.22.2 Teva Mefenamic Acid Description and Business Overview
6.22.3 Teva Mefenamic Acid Sales, Revenue and Gross Margin (2016-2021)
6.22.4 Teva Product Portfolio
6.22.5 Teva Recent Developments/Updates
6.23 Wockhardt
6.23.1 Wockhardt Corporation Information
6.23.2 Wockhardt Mefenamic Acid Description and Business Overview
6.23.3 Wockhardt Mefenamic Acid Sales, Revenue and Gross Margin (2016-2021)
6.23.4 Wockhardt Product Portfolio
6.23.5 Wockhardt Recent Developments/Updates
6.24 Esteve
6.24.1 Esteve Corporation Information
6.24.2 Esteve Mefenamic Acid Description and Business Overview
6.24.3 Esteve Mefenamic Acid Sales, Revenue and Gross Margin (2016-2021)
6.24.4 Esteve Product Portfolio
6.24.5 Esteve Recent Developments/Updates

7 Mefenamic Acid Manufacturing Cost Analysis
7.1 Mefenamic Acid Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Mefenamic Acid
7.4 Mefenamic Acid Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Mefenamic Acid Distributors List
8.3 Mefenamic Acid Customers

9 Mefenamic Acid Market Dynamics
9.1 Mefenamic Acid Industry Trends
9.2 Mefenamic Acid Growth Drivers
9.3 Mefenamic Acid Market Challenges
9.4 Mefenamic Acid Market Restraints

10 Global Market Forecast
10.1 Mefenamic Acid Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Mefenamic Acid by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Mefenamic Acid by Type (2022-2027)
10.2 Mefenamic Acid Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Mefenamic Acid by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Mefenamic Acid by Application (2022-2027)
10.3 Mefenamic Acid Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Mefenamic Acid by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Mefenamic Acid by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Mefenamic Acid Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Mefenamic Acid Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Mefenamic Acid Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Mefenamic Acid Covered in This Study
Table 5. Global Mefenamic Acid Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Mefenamic Acid Sales Share by Manufacturers (2016-2021)
Table 7. Global Mefenamic Acid Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Mefenamic Acid Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Mefenamic Acid Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Mefenamic Acid Manufacturing Sites and Area Served
Table 11. Manufacturers Mefenamic Acid Product Type
Table 12. Global Mefenamic Acid Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Mefenamic Acid by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mefenamic Acid as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Mefenamic Acid Sales by Region (2016-2021) & (K Units)
Table 16. Global Mefenamic Acid Sales Market Share by Region (2016-2021)
Table 17. Global Mefenamic Acid Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Mefenamic Acid Sales by Country (2016-2021) & (K Units)
Table 19. North America Mefenamic Acid Sales Market Share by Country (2016-2021)
Table 20. North America Mefenamic Acid Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Mefenamic Acid Revenue Market Share by Country (2016-2021)
Table 22. Europe Mefenamic Acid Sales by Country (2016-2021) & (K Units)
Table 23. Europe Mefenamic Acid Sales Market Share by Country (2016-2021)
Table 24. Europe Mefenamic Acid Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Mefenamic Acid Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Mefenamic Acid Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Mefenamic Acid Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Mefenamic Acid Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Mefenamic Acid Revenue Market Share by Region (2016-2021)
Table 30. Latin America Mefenamic Acid Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Mefenamic Acid Sales Market Share by Country (2016-2021)
Table 32. Latin America Mefenamic Acid Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Mefenamic Acid Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Mefenamic Acid Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Mefenamic Acid Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Mefenamic Acid Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Mefenamic Acid Revenue Market Share by Country (2016-2021)
Table 38. Global Mefenamic Acid Sales (K Units) by Type (2016-2021)
Table 39. Global Mefenamic Acid Sales Market Share by Type (2016-2021)
Table 40. Global Mefenamic Acid Revenue (Million US$) by Type (2016-2021)
Table 41. Global Mefenamic Acid Revenue Share by Type (2016-2021)
Table 42. Global Mefenamic Acid Price (US$/Unit) by Type (2016-2021)
Table 43. Global Mefenamic Acid Sales (K Units) by Application (2016-2021)
Table 44. Global Mefenamic Acid Sales Market Share by Application (2016-2021)
Table 45. Global Mefenamic Acid Revenue (Million US$) by Application (2016-2021)
Table 46. Global Mefenamic Acid Revenue Share by Application (2016-2021)
Table 47. Global Mefenamic Acid Price (US$/Unit) by Application (2016-2021)
Table 48. Shionogi Pharma Corporation Information
Table 49. Shionogi Pharma Description and Business Overview
Table 50. Shionogi Pharma Mefenamic Acid Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Shionogi Pharma Mefenamic Acid Product
Table 52. Shionogi Pharma Recent Developments/Updates
Table 53. Solitaire Pharmacia Corporation Information
Table 54. Solitaire Pharmacia Description and Business Overview
Table 55. Solitaire Pharmacia Mefenamic Acid Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Solitaire Pharmacia Mefenamic Acid Product
Table 57. Solitaire Pharmacia Recent Developments/Updates
Table 58. Shinto Organics Corporation Information
Table 59. Shinto Organics Description and Business Overview
Table 60. Shinto Organics Mefenamic Acid Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Shinto Organics Mefenamic Acid Product
Table 62. Shinto Organics Recent Developments/Updates
Table 63. Captab Corporation Information
Table 64. Captab Description and Business Overview
Table 65. Captab Mefenamic Acid Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Captab Mefenamic Acid Product
Table 67. Captab Recent Developments/Updates
Table 68. EMS Pharma Corporation Information
Table 69. EMS Pharma Description and Business Overview
Table 70. EMS Pharma Mefenamic Acid Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. EMS Pharma Mefenamic Acid Product
Table 72. EMS Pharma Recent Developments/Updates
Table 73. Adelco Corporation Information
Table 74. Adelco Description and Business Overview
Table 75. Adelco Mefenamic Acid Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Adelco Mefenamic Acid Product
Table 77. Adelco Recent Developments/Updates
Table 78. Agron Remedies Corporation Information
Table 79. Agron Remedies Description and Business Overview
Table 80. Agron Remedies Mefenamic Acid Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Agron Remedies Mefenamic Acid Product
Table 82. Agron Remedies Recent Developments/Updates
Table 83. IASIS Pharmaceuticals Hellas Corporation Information
Table 84. IASIS Pharmaceuticals Hellas Description and Business Overview
Table 85. IASIS Pharmaceuticals Hellas Mefenamic Acid Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. IASIS Pharmaceuticals Hellas Mefenamic Acid Product
Table 87. IASIS Pharmaceuticals Hellas Recent Developments/Updates
Table 88. ABL Lifecare Corporation Information
Table 89. ABL Lifecare Description and Business Overview
Table 90. ABL Lifecare Mefenamic Acid Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. ABL Lifecare Mefenamic Acid Product
Table 92. ABL Lifecare Recent Developments/Updates
Table 93. Farmo Quimica Corporation Information
Table 94. Farmo Quimica Description and Business Overview
Table 95. Farmo Quimica Mefenamic Acid Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Farmo Quimica Mefenamic Acid Product
Table 97. Farmo Quimica Recent Developments/Updates
Table 98. Apotex Corporation Information
Table 99. Apotex Description and Business Overview
Table 100. Apotex Mefenamic Acid Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Apotex Mefenamic Acid Product
Table 102. Apotex Recent Developments/Updates
Table 103. Sanofi Aventis Corporation Information
Table 104. Sanofi Aventis Description and Business Overview
Table 105. Sanofi Aventis Mefenamic Acid Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Sanofi Aventis Mefenamic Acid Product
Table 107. Sanofi Aventis Recent Developments/Updates
Table 108. Yung Sine Corporation Information
Table 109. Yung Sine Description and Business Overview
Table 110. Yung Sine Mefenamic Acid Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Yung Sine Mefenamic Acid Product
Table 112. Yung Sine Recent Developments/Updates
Table 113. Streuli Pharma, Corporation Information
Table 114. Streuli Pharma, Description and Business Overview
Table 115. Streuli Pharma, Mefenamic Acid Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Streuli Pharma, Mefenamic Acid Product
Table 117. Streuli Pharma, Recent Developments/Updates
Table 118. Mankind Corporation Information
Table 119. Mankind Description and Business Overview
Table 120. Mankind Mefenamic Acid Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Mankind Mefenamic Acid Product
Table 122. Mankind Recent Developments/Updates
Table 123. Pfizer Corporation Information
Table 124. Pfizer Description and Business Overview
Table 125. Pfizer Mefenamic Acid Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Pfizer Mefenamic Acid Product
Table 127. Pfizer Recent Developments/Updates
Table 128. Daiichi Sankyo Corporation Information
Table 129. Daiichi Sankyo Description and Business Overview
Table 130. Daiichi Sankyo Mefenamic Acid Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Daiichi Sankyo Mefenamic Acid Product
Table 132. Daiichi Sankyo Recent Developments/Updates
Table 133. Chemidex Pharma Corporation Information
Table 134. Chemidex Pharma Description and Business Overview
Table 135. Chemidex Pharma Mefenamic Acid Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. Chemidex Pharma Mefenamic Acid Product
Table 137. Chemidex Pharma Recent Developments/Updates
Table 138. AA Pharma Corporation Information
Table 139. AA Pharma Description and Business Overview
Table 140. AA Pharma Mefenamic Acid Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 141. AA Pharma Mefenamic Acid Product
Table 142. AA Pharma Recent Developments/Updates
Table 143. Nisshin Pharmaceutical Corporation Information
Table 144. Nisshin Pharmaceutical Description and Business Overview
Table 145. Nisshin Pharmaceutical Mefenamic Acid Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 146. Nisshin Pharmaceutical Mefenamic Acid Product
Table 147. Nisshin Pharmaceutical Recent Developments/Updates
Table 148. Koa Isei Corporation Information
Table 149. Koa Isei Description and Business Overview
Table 150. Koa Isei Mefenamic Acid Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 151. Koa Isei Mefenamic Acid Product
Table 152. Koa Isei Recent Developments/Updates
Table 153. Teva Corporation Information
Table 154. Teva Description and Business Overview
Table 155. Teva Mefenamic Acid Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 156. Teva Mefenamic Acid Product
Table 157. Teva Recent Developments/Updates
Table 158. Wockhardt Corporation Information
Table 159. Wockhardt Description and Business Overview
Table 160. Wockhardt Mefenamic Acid Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 161. Wockhardt Mefenamic Acid Product
Table 162. Wockhardt Recent Developments/Updates
Table 163. Esteve Corporation Information
Table 164. Esteve Description and Business Overview
Table 165. Esteve Mefenamic Acid Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 166. Esteve Mefenamic Acid Product
Table 167. Esteve Recent Developments/Updates
Table 168. Production Base and Market Concentration Rate of Raw Material
Table 169. Key Suppliers of Raw Materials
Table 170. Mefenamic Acid Distributors List
Table 171. Mefenamic Acid Customers List
Table 172. Mefenamic Acid Market Trends
Table 173. Mefenamic Acid Growth Drivers
Table 174. Mefenamic Acid Market Restraints
Table 175. Global Mefenamic Acid Sales Forecast by Type (2022-2027) & (K Units)
Table 176. Global Mefenamic Acid Sales Market Share Forecast by Type (2022-2027)
Table 177. Global Mefenamic Acid Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 178. Global Mefenamic Acid Revenue Market Share Forecast by Type (2022-2027)
Table 179. Global Mefenamic Acid Sales Forecast by Application (2022-2027) & (K Units)
Table 180. Global Mefenamic Acid Sales Market Share Forecast by Application (2022-2027)
Table 181. Global Mefenamic Acid Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 182. Global Mefenamic Acid Revenue Market Share Forecast by Application (2022-2027)
Table 183. Global Mefenamic Acid Sales Forecast by Region (2022-2027) & (K Units)
Table 184. Global Mefenamic Acid Sales Market Share Forecast by Region (2022-2027)
Table 185. Global Mefenamic Acid Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 186. Global Mefenamic Acid Revenue Market Share Forecast by Region (2022-2027)
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Mefenamic Acid
Figure 2. Global Mefenamic Acid Market Share by Type in 2020 & 2027
Figure 3. Patent Product Picture
Figure 4. Generic Product Picture
Figure 5. Global Mefenamic Acid Market Share by Application in 2020 & 2027
Figure 6. Hospital
Figure 7. Drug Store
Figure 8. On-line
Figure 9. Global Mefenamic Acid Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Mefenamic Acid Market Size 2016-2027 (US$ Million)
Figure 11. Global Mefenamic Acid Sales 2016-2027 (K Units)
Figure 12. Global Mefenamic Acid Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Mefenamic Acid Sales Share by Manufacturers in 2020
Figure 14. Global Mefenamic Acid Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Mefenamic Acid Players: Market Share by Revenue in 2020
Figure 16. Mefenamic Acid Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Mefenamic Acid Sales Market Share by Region (2016-2021)
Figure 18. Global Mefenamic Acid Sales Market Share by Region in 2020
Figure 19. Global Mefenamic Acid Revenue Market Share by Region (2016-2021)
Figure 20. Global Mefenamic Acid Revenue Market Share by Region in 2020
Figure 21. U.S. Mefenamic Acid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Mefenamic Acid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Mefenamic Acid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Mefenamic Acid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Mefenamic Acid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Mefenamic Acid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Mefenamic Acid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Mefenamic Acid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Mefenamic Acid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Mefenamic Acid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Mefenamic Acid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Mefenamic Acid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Taiwan Mefenamic Acid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Mefenamic Acid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Mefenamic Acid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Mefenamic Acid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Philippines Mefenamic Acid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Vietnam Mefenamic Acid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Mexico Mefenamic Acid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Brazil Mefenamic Acid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Argentina Mefenamic Acid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Turkey Mefenamic Acid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Saudi Arabia Mefenamic Acid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. UAE Mefenamic Acid Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Sales Market Share of Mefenamic Acid by Type (2016-2021)
Figure 46. Sales Market Share of Mefenamic Acid by Application (2016-2021)
Figure 47. Sales Market Share of Mefenamic Acid by Application in 2020
Figure 48. Revenue Share of Mefenamic Acid by Application (2016-2021)
Figure 49. Revenue Share of Mefenamic Acid by Application in 2020
Figure 50. Manufacturing Cost Structure of Mefenamic Acid
Figure 51. Manufacturing Process Analysis of Mefenamic Acid
Figure 52. Mefenamic Acid Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed